Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane in Ovarian Cancer Surgery
NCT05606692Phase 4Recruiting
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Nov 2022
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol injection (veterinary) in ovarian cancer (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Progression-Free Survival at 5 years. Started Nov 2022; status: recruiting.
02
Drugs
propofol injection (veterinary)
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05606692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05606692.